These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 85409)

  • 21. The acute hemodynamic changes of beta-adrenergic blockade in patients with thyrotoxicosis.
    Schweitzer P; Pivonka M; Zeman R; Gregorová J; Merstenová E
    Z Kreislaufforsch; 1968 Dec; 57(12):1212-20. PubMed ID: 4387873
    [No Abstract]   [Full Text] [Related]  

  • 22. Myocardial contractility, and the effects of beta-adrenergic blockade in hypothyroidism and hyperthyroidism.
    Howitt G; Rowlands DJ; Leung DY; Logan WF
    Clin Sci; 1968 Jun; 34(3):485-95. PubMed ID: 5662591
    [No Abstract]   [Full Text] [Related]  

  • 23. [Chronic administration of beta blocking agents: left ventricular hemodynamics in myocardial infarctions during exercise (author's transl)].
    Blümchen G; Esche HH
    Z Kardiol; 1981 Sep; 70(9):678-86. PubMed ID: 7303806
    [No Abstract]   [Full Text] [Related]  

  • 24. Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.
    Ikram H
    Br Med J; 1977 Jun; 1(6075):1505-7. PubMed ID: 871633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics in drug therapy. I: Propranolol hydrochloride as adjunct therapy in the treatment of thyrotoxicosis.
    Robayo JR
    Am J Hosp Pharm; 1976 Feb; 33(2):169-73. PubMed ID: 56890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiographic comparison of haemodynamic effects of metoprolol and propranolol.
    Bett JH; Dryburgh L; Hetherington DE
    Br Heart J; 1980 May; 43(5):541-5. PubMed ID: 7378213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyrotoxicosis presenting as choreoathetosis.
    Heffron W; Eaton RP
    Ann Intern Med; 1970 Sep; 73(3):425-8. PubMed ID: 4195476
    [No Abstract]   [Full Text] [Related]  

  • 28. Propranolol as an adjunct therapy for hyperthyroid tremor.
    Henderson JM; Portmann L; Van Melle G; Haller E; Ghika JA
    Eur Neurol; 1997; 37(3):182-5. PubMed ID: 9137929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenergic control of myocardial contractility in conscious hyperthyroid dogs.
    Rutherford JD; Vatner SF; Braunwald E
    Am J Physiol; 1979 Nov; 237(5):H590-6. PubMed ID: 495765
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacodynamics of inotropic and chronotropic responses to oral therapy with propranolol. Studies in normal subjects and patients with angina.
    Boudoulas H; Beaver BM; Kates RE; Lewis RP
    Chest; 1978 Feb; 73(2):146-53. PubMed ID: 340158
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.
    Sgarbi JA; Villaça FG; Garbeline B; Villar HE; Romaldini JH
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1672-7. PubMed ID: 12679455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Change in central hemodynamics in patients with thyrotoxicosis before and after treatment].
    Litvinenko AF
    Kardiologiia; 1972 Apr; 12(4):92-6. PubMed ID: 4114627
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of propranolol in hyperthyroidism].
    Ishii Y; Nakano Y; Fukase M; Torizuka K; Mori T
    Nihon Rinsho; 1968 Jan; 26(1):169-74. PubMed ID: 5748520
    [No Abstract]   [Full Text] [Related]  

  • 34. Sympathetic nervous system blocking in hyperthyroidism.
    Vinik AI; Pimstone BL; Hoffenberg R
    J Clin Endocrinol Metab; 1968 May; 28(5):725-7. PubMed ID: 4172456
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of severe thyrotoxicosis with potassium iodide and propranolol.
    Nicol EF; Irvine WJ
    Scott Med J; 1982 Apr; 27(2):172-4. PubMed ID: 7089529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of propranolol (obsidan) on myocardial contractility].
    Ovsiannikov VI; Khashimov KhA; Kostko SZ
    Kardiologiia; 1976 Aug; 16(8):126-7. PubMed ID: 1011495
    [No Abstract]   [Full Text] [Related]  

  • 37. Five-year follow-up of thyrotoxicosis treated with antithyroid drugs.
    Thalassinos NC; Oakley NW; Russell Fraser T
    Endokrinologie; 1974 Sep; 63(3):325-30. PubMed ID: 4143392
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in maximal gastric secretion in patients with hyperthyroidism caused by thyrostatic treatment].
    Zdichynec B; Holzerová O; Kobza R; Polácek I
    Cesk Gastroenterol Vyz; 1977 Oct; 31(7):448-53. PubMed ID: 74292
    [No Abstract]   [Full Text] [Related]  

  • 39. Left ventricular function and hyperthyroidism.
    Merillon JP; Passa P; Chastre J; Wolf A; Gourgon R
    Br Heart J; 1981 Aug; 46(2):137-43. PubMed ID: 7272124
    [No Abstract]   [Full Text] [Related]  

  • 40. [Headache secondary to hyperthyroidism].
    Sempere ÁP; Moreno-Pérez Ó; Portugués-Vegara MJ; Jiménez-Sola D
    Rev Neurol; 2010 Oct; 51(8):511-2. PubMed ID: 20925035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.